Literature DB >> 11891275

An unusual Fc receptor-related protein expressed in human centroblasts.

Fabio Facchetti1, Marina Cella, Silvana Festa, Daved H Fremont, Marco Colonna.   

Abstract

Here, we report the identification of Fc receptor homolog expressed in B cells (FREB), a unique B cell-specific molecule that is distantly related to FcgammaRI (receptor I for the Fc fragment of IgG) and is encoded on human chromosome 1q, within the FcgammaR gene region. FREB has an intracellular distribution and lacks a canonical transmembrane domain. In addition, FREB lacks bona fide Fc fragment binding regions and does not bind immunoglobulins. By using specific monoclonal antibodies, we show that FREB is preferentially expressed in germinal center centroblasts, which undergo affinity maturation and class-switch recombination. Together, these characteristics indicate that FREB may have a unique role in B cell differentiation. FREB is also expressed in some B cell lymphomas, most of which have centroblast origin. Remarkably, FREB is expressed in a subset of diffuse large B cell lymphomas, providing a unique marker for the characterization of this B cell malignancy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11891275      PMCID: PMC122600          DOI: 10.1073/pnas.022042699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Identification of a family of Fc receptor homologs with preferential B cell expression.

Authors:  R S Davis; Y H Wang; H Kubagawa; M D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-07       Impact factor: 11.205

2.  Molecular basis for immune complex recognition: a comparison of Fc-receptor structures.

Authors:  P Sondermann; J Kaiser; U Jacob
Journal:  J Mol Biol       Date:  2001-06-08       Impact factor: 5.469

Review 3.  Myeloma based expression system for production of large mammalian proteins.

Authors:  A Traunecker; F Oliveri; K Karjalainen
Journal:  Trends Biotechnol       Date:  1991-04       Impact factor: 19.536

4.  FCRL, a novel member of the leukocyte Fc receptor family possesses unique structural features.

Authors:  Ludmila V Mechetina; Alexander M Najakshin; Olga Y Volkova; Sergei V Guselnikov; Rafik Z Faizulin; Boris Y Alabyev; Nikolai A Chikaev; Maria S Vinogradova; Alexander V Taranin
Journal:  Eur J Immunol       Date:  2002-01       Impact factor: 5.532

Review 5.  Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus.

Authors:  R D Teasdale; M R Jackson
Journal:  Annu Rev Cell Dev Biol       Date:  1996       Impact factor: 13.827

Review 6.  IgG Fc receptors.

Authors:  J V Ravetch; S Bolland
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

Review 7.  Germinal centers.

Authors:  I C MacLennan
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

8.  IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy.

Authors:  G Hatzivassiliou; I Miller; J Takizawa; N Palanisamy; P H Rao; S Iida; S Tagawa; M Taniwaki; J Russo; A Neri; G Cattoretti; R Clynes; C Mendelsohn; R S Chaganti; R Dalla-Favera
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

9.  Expression of immunoglobulin and scavenger receptor superfamily domains as chimeric proteins with domains 3 and 4 of CD4 for ligand analysis.

Authors:  M H Brown; A N Barclay
Journal:  Protein Eng       Date:  1994-04

Review 10.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

View more
  12 in total

1.  Differential expression of FCRLA in naïve and activated mouse B cells.

Authors:  Evdokiya S Reshetnikova; Ludmila V Mechetina; Olga Y Volkova; Sergey V Guselnikov; Nikolai A Chikaev; Dorottya Kövesdi; Boris Alabyev; Gabriella Sármay; Peter D Burrows; Alexander M Najakshin; Alexander V Taranin
Journal:  Cell Immunol       Date:  2011-10-22       Impact factor: 4.868

2.  Identification of context-dependent expression quantitative trait loci in whole blood.

Authors:  Daria V Zhernakova; Patrick Deelen; Martijn Vermaat; Maarten van Iterson; Michiel van Galen; Wibowo Arindrarto; Peter van 't Hof; Hailiang Mei; Freerk van Dijk; Harm-Jan Westra; Marc Jan Bonder; Jeroen van Rooij; Marijn Verkerk; P Mila Jhamai; Matthijs Moed; Szymon M Kielbasa; Jan Bot; Irene Nooren; René Pool; Jenny van Dongen; Jouke J Hottenga; Coen D A Stehouwer; Carla J H van der Kallen; Casper G Schalkwijk; Alexandra Zhernakova; Yang Li; Ettje F Tigchelaar; Niek de Klein; Marian Beekman; Joris Deelen; Diana van Heemst; Leonard H van den Berg; Albert Hofman; André G Uitterlinden; Marleen M J van Greevenbroek; Jan H Veldink; Dorret I Boomsma; Cornelia M van Duijn; Cisca Wijmenga; P Eline Slagboom; Morris A Swertz; Aaron Isaacs; Joyce B J van Meurs; Rick Jansen; Bastiaan T Heijmans; Peter A C 't Hoen; Lude Franke
Journal:  Nat Genet       Date:  2016-12-05       Impact factor: 38.330

Review 3.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

4.  Defining the immunological phenotype of Fc receptor-like B (FCRLB) deficient mice: Confounding role of the inhibitory FcγRIIb.

Authors:  Keiji Masuda; Hiromi Mori; Osamu Ohara; Manabu Nakayama; Ji-Yang Wang; Peter D Burrows
Journal:  Cell Immunol       Date:  2010       Impact factor: 4.868

5.  FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA.

Authors:  Teresa Santiago; Sergei V Kulemzin; Evdokia S Reshetnikova; Nikolai A Chikaev; Olga Y Volkova; Ludmila V Mechetina; Meina Zhao; Randall S Davis; Alexander V Taranin; Alexander M Najakshin; Linda M Hendershot; Peter D Burrows
Journal:  Int Immunol       Date:  2010-12-13       Impact factor: 4.823

6.  Cutting edge: human FcRL4 and FcRL5 are receptors for IgA and IgG.

Authors:  Timothy J Wilson; Anja Fuchs; Marco Colonna
Journal:  J Immunol       Date:  2012-04-09       Impact factor: 5.422

7.  Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells.

Authors:  Hua Shen; Cliona M McHale; Syed I Haider; Cham Jung; Susie Zhang; Martyn T Smith; Luoping Zhang
Journal:  Toxicol Sci       Date:  2016-03-22       Impact factor: 4.849

8.  Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.

Authors:  Carole Le Coz; David N Nguyen; Chun Su; Brian E Nolan; Amanda V Albrecht; Suela Xhani; Di Sun; Benjamin Demaree; Piyush Pillarisetti; Caroline Khanna; Francis Wright; Peixin Amy Chen; Samuel Yoon; Amy L Stiegler; Kelly Maurer; James P Garifallou; Amy Rymaszewski; Steven H Kroft; Timothy S Olson; Alix E Seif; Gerald Wertheim; Struan F A Grant; Linda T Vo; Jennifer M Puck; Kathleen E Sullivan; John M Routes; Viktoria Zakharova; Anna Shcherbina; Anna Mukhina; Natasha L Rudy; Anna C E Hurst; T Prescott Atkinson; Titus J Boggon; Hakon Hakonarson; Adam R Abate; Joud Hajjar; Sarah K Nicholas; James R Lupski; James Verbsky; Ivan K Chinn; Michael V Gonzalez; Andrew D Wells; Alex Marson; Gregory M K Poon; Neil Romberg
Journal:  J Exp Med       Date:  2021-05-05       Impact factor: 14.307

9.  Species-specific evolution of the FcR family in endothermic vertebrates.

Authors:  Svetlana A Fayngerts; Alexander M Najakshin; Alexander V Taranin
Journal:  Immunogenetics       Date:  2007-03-14       Impact factor: 3.330

10.  Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.

Authors:  Genaro Pimienta; Victor Fok; Maria Haslip; Maria Nagy; Seyedtaghi Takyar; Joan A Steitz
Journal:  PLoS One       Date:  2015-06-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.